Exagen, Inc. (XGN)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
May 08, 16:00
2.96
+0.01
(+0.34%)
Pre-Market: 20:00
Exagen Profit Margin (Quarterly) : -28.10% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Veracyte, Inc. | 20.64% |
| Insight Molecular Diagnostics, Inc. | -2.02K% |
| bioAffinity Technologies, Inc. | -268.6% |
| GRAIL, Inc. | -228.5% |
| FONAR Corp. | 9.94% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -137.5% |
| Return on Assets | -37.43% |
| Return on Invested Capital | -49.78% |
| Gross Profit Margin (Quarterly) | 55.35% |
| Operating Margin (Quarterly) | -29.91% |
| Return on Net Operating Assets | -77.92% |